Expert perspectives for the pharmacist on facilitating and improving the use of albumin in cirrhosis

By sjmartinez • April 5, 2023

Kugelmas M, Loftus M, Owen EJ, Wadei H, Saab S. Expert perspectives for the pharmacist on facilitating and improving the use of albumin in cirrhosis. Am J Health Syst Pharm. 2023 Apr 4:zxad070. doi: 10.1093/ajhp/zxad070. Epub ahead of print. PMID: 37013893.

Tags: albumin, ascites, Cirrhosis, Digestive Diseases, hepatorenal syndrome, Publications, spontaneous bacterial peritonitis, terlipressin

Related Posts

Optimizing breast cancer chemotherapy by harnessing gut microbiota with insights from artificial intelligence

Zhou Y, Jiang M, Shen K, He T, Zhou S, Shao A, Li X, Wang J, Wu R, Singla RK, Jacobs JP, Shen B. Optimizing[...]

Microbiota and short chain fatty acid relationships underlie clinical heterogeneity and identify key microbial targets in irritable bowel syndrome (IBS)

Shin AS, Xing Y, Waseem MR, Siwiec R, James-Stevenson T, Rogers N, Bohm M, Wo J, Lockett C, Gupta A, Kadariya J, Toh E, Anderson[...]

Corrigendum to “Subchronic inhalation exposure to ultrafine particulate matter alters the intestinal microbiome in various mouse models” [Environ. Res. 248 (2024) 118242]

Chang C, Gupta R, Sedighian F, Louie A, Gonzalez DM, Le C, Cho JM, Park SK, Castellanos J, Ting TW, Dong TS, Arias-Jayo N, Lagishetty[...]